On the other hand, insufficient evidence supports an altered analgesic reaction or dosing suggestions for this kind of variants.[19] This concept illustrates the complexity of genetic polymorphisms as well as clinical implications affiliated with opioid therapy. A monitored placing is suggested for high-chance patients starting up opioid therapy